🔎 Trials Near Me

Home › Ulcerative Colitis › Nevada › Las Vegas

Ulcerative Colitis clinical trials in Las Vegas, NV

6 studies for Ulcerative Colitis are looking for participants at sites in and around Las Vegas (within about 30 miles). Open a study to see who can join and how to contact the study team.

Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

RecruitingPhase 2
  • Vector Clinical Trials /ID# 280843, Las Vegas
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07697456

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

RecruitingPhase 2
  • Vector Clinical Trials, Las Vegas
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483073

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 2
  • Digestive Disease Specialists - Las Vegas - Crimson Canyon Drive, Las Vegas
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

RecruitingPhase 3
  • Las Vegas Clinical Trials - Site Number: 8400079, Las Vegas
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996

BOOM-IBD2 Pivotal Clinical Trial

Recruiting
  • Las Vegas Medical Research LLC, DBA Vector Clinical Trials, Las Vegas
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

RecruitingPhase 2
  • Mirador Therapeutics Selected Site, Las Vegas
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522

About Ulcerative Colitis

Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.

More about Ulcerative Colitis on MedlinePlus

Ulcerative Colitis trials in other cities

Other studies in Las Vegas

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.